PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Continente #
NA - Nord America 7603
EU - Europa 2975
AS - Asia 704
AF - Africa 11
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 11313
Nazione #
US - Stati Uniti d'America 7499
IT - Italia 696
DE - Germania 671
CN - Cina 534
SE - Svezia 497
UA - Ucraina 290
AT - Austria 179
GB - Regno Unito 152
CA - Canada 102
IE - Irlanda 102
FR - Francia 96
RU - Federazione Russa 85
VN - Vietnam 64
DK - Danimarca 63
FI - Finlandia 58
TR - Turchia 40
BE - Belgio 27
NL - Olanda 26
IN - India 22
JP - Giappone 22
ES - Italia 15
IR - Iran 6
CH - Svizzera 5
EU - Europa 5
KR - Corea 5
AU - Australia 3
CO - Colombia 3
EG - Egitto 3
PE - Perù 3
PL - Polonia 3
RO - Romania 3
SC - Seychelles 3
SG - Singapore 3
BG - Bulgaria 2
BR - Brasile 2
HK - Hong Kong 2
HR - Croazia 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BT - Bhutan 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
PA - Panama 1
PT - Portogallo 1
TW - Taiwan 1
Totale 11313
Città #
Ann Arbor 2328
Woodbridge 670
Fairfield 669
Chandler 562
Frankfurt am Main 476
Houston 475
Wilmington 463
Jacksonville 297
Seattle 284
Ashburn 281
Dearborn 261
Cambridge 222
Princeton 194
Vienna 178
Milan 148
Nanjing 139
Dublin 102
Lawrence 92
Altamura 91
San Diego 53
Dong Ket 48
Beijing 43
Lachine 43
Nanchang 42
Falls Church 37
Guangzhou 32
Lissone 32
Andover 31
Shenyang 30
Jinan 29
Brussels 27
Tianjin 27
Boardman 24
Ottawa 23
London 22
Hebei 20
Zhengzhou 19
Changsha 18
Ningbo 18
Philadelphia 18
Kunming 16
Norwalk 16
Toronto 16
Fremont 15
Hangzhou 15
Jiaxing 15
Huizen 13
Redmond 13
Edmonton 12
Kocaeli 12
Auburn Hills 11
Rome 11
Monza 10
Kiev 9
Mountain View 8
Nürnberg 8
San Mateo 8
Taizhou 8
Hefei 7
Leawood 7
Paullo 7
Detroit 6
Duncan 6
Montréal 6
Saint Louis 6
Chicago 5
Helsinki 5
Pavia 5
Taiyuan 5
University Park 5
Abbiategrasso 4
Bologna 4
Cernusco sul Naviglio 4
Changchun 4
Chengdu 4
Daejeon 4
Lanzhou 4
Levate 4
Los Angeles 4
Simi Valley 4
Soresina 4
Tokyo 4
Buccinasco 3
Catania 3
Dallas 3
Fuzhou 3
Genova 3
Groningen 3
La Mancha 3
Lardirago 3
Napoli 3
Oggiono 3
Qualiano 3
Rozzano 3
Saint Petersburg 3
Shanghai 3
Shenzhen 3
Singapore 3
Trezzano Sul Naviglio 3
Verona 3
Totale 8956
Nome #
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 308
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 301
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 283
MALDI imaging in Fabry nephropathy: a multicenter study 279
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 235
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 232
Microscopic Polyangiitis 221
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 213
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 208
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 201
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 197
Kidney Involvement 195
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 191
The putative role of MALDI-MSI in the study of Membranous Nephropathy 189
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 189
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 188
Proteomics for the study of new biomarkers in Fabry disease: State of the art 179
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 175
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 164
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 159
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 158
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 156
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 154
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 154
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 149
Parapelvic cysts, a distinguishing feature of renal Fabry disease 147
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 146
Obesity-associated hypertension in childhood: A new epidemic problem 145
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 143
Role of fat distribution indicators in the identification of hypertension in children 141
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 139
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 139
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 136
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 134
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 133
Usefulness of waist circumference for the identification of childhood hypertension 132
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 129
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 129
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 126
Renal afferents signaling diuretic activity in the cat 125
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 122
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 120
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 119
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 117
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 115
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 115
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 114
ANCA-associated vasculitis in childhood: Recent advances 112
Hypertension in childhood: autonomic and metabolic patterns 110
Anticoagulant-related nephropathy: a pathological note 110
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 108
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 108
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 106
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 104
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 103
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 102
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 101
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 101
Avacopan for the treatment of ANCA-associated vasculitis 99
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 97
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 97
Redefining the pulvinar sign in fabry disease 94
Analysis of heart period and arterial pressure variability in childhood hypertension: key role of baroreflex impairment 93
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 93
Sympathetic activation in cardiovascular and renal disease 91
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 91
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 88
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 86
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 84
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 83
[Clinical and histological findings in Fabry nephropathy] 83
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 80
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 80
The children of dialysis: Live-born babies from on-dialysis mothers in Italy - An epidemiological perspective comparing dialysis, kidney transplantation and the overall population 80
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 80
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 78
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 74
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 73
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 71
Tumour incidence in Fabry disease: A cross-sectional study 69
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 69
La diagnosi precoce di malattia 65
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 62
La terapia enzimatica sostitutiva nella malattia di Fabry 62
Cardiological follow-up in patients with Fabry disease 60
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 60
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 56
Heart involvement in Anderson-Fabry disease: Italian recommendations for diagnostic, follow-up and therapeutic management [Il coinvolgimento cardiaco nella malattia di Anderson-Fabry: Nuove raccomandazioni sulla diagnosi, il follow-up e la terapia] 53
SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience 51
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 50
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 48
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 42
Renal reflexes and denervation in heart failure 41
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2020), 10.1007/s40620-020-00774-5) 34
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement 33
The GALA project: Practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts 32
Migalastat treatment in a kidney-transplanted patient with fabry disease and n215s mutation: The first case report 21
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 11
Totale 11823
Categoria #
all - tutte 21592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21592


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018127 0000 00 00 000127
2018/20191185 39482223 69110 8373 87101223307
2019/20202176 275131173167 185275 303162 20511414739
2020/20212474 12679210228 211251 278308 218215148202
2021/20221614 155198187148 115140 4781 7391117262
2022/20232319 255725192177 154357 50133 17125800
Totale 11823